Open Access

[Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy

  • Authors:
    • Min Yong
    • Tinghe Yu
    • Si Tian
    • Shuaibin Liu
    • Jiao Xu
    • Jianguo Hu
    • Lina Hu
  • View Affiliations

  • Published online on: January 9, 2020     https://doi.org/10.3892/ol.2020.11285
  • Pages: 2072-2072
  • Copyright : © Yong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

March-2020
Volume 19 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yong M, Yu T, Tian S, Liu S, Xu J, Hu J and Hu L: [Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy. Oncol Lett 19: 2072-2072, 2020
APA
Yong, M., Yu, T., Tian, S., Liu, S., Xu, J., Hu, J., & Hu, L. (2020). [Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy. Oncology Letters, 19, 2072-2072. https://doi.org/10.3892/ol.2020.11285
MLA
Yong, M., Yu, T., Tian, S., Liu, S., Xu, J., Hu, J., Hu, L."[Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy". Oncology Letters 19.3 (2020): 2072-2072.
Chicago
Yong, M., Yu, T., Tian, S., Liu, S., Xu, J., Hu, J., Hu, L."[Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy". Oncology Letters 19, no. 3 (2020): 2072-2072. https://doi.org/10.3892/ol.2020.11285